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1. INTRODUCTION 2. MATERIALS AND METHODS 
Enhanced lipogenesis has been observed in 
livers of genetically obese mice [ 1,2]. This might be 
one of the mechanisms responsible for the in- 
creased fat deposition which occurs in these ani- 
mals. Liver glycolysis provides C3 units for the 
synthesis of lipids and thus is an important compo- 
nent of the control of lipogenesis. A defective al- 
losteric regulation of phosphofructokinase has 
been observed in livers of genetically obese mice 
[3]. The defect, consisting of a decreased sensitivity 
towards ATP inhibition, might be explained by the 
presence of an excessive amount of fructose 2,6- 
bisphosphate in livers of these animals. Indeed, 
fructose 2,6_bisphosphate, the newly discovered 
stimulator of PFK [4,5], is capable of relieving in- 
hibition by ATP [6,7]. It is formed in livers exposed 
to glucose and is degraded after the administration 
of glucagon or upon starvation [4,5]. An elevated 
fructose 2,6-bisphosphate content in livers of obese 
mice may explain an enhanced glycolysis and con- 
sequently may offer a partial explanation for the 
increased lipogenesis observed in the livers of 
these animals. 
Male obese (C57BL/6J-ob/ob) mice and their 
control lean littermates (obtained from the Jackson 
Laboratories, Bar Harbor, Maine, USA) were fed 
ad libitum, or starved, for 15 h overnight before 
the experiment. Mice which were 25 weeks old 
were chosen since it is known that their glycemia is 
not different from the value in control lean mice 
[8]. After 15 min of anesthesia (pentobarbital, 0.1 
mg/g body weight intraperitoneally) the abdomen 
was opened, blood samples were taken and the 
livers were quickly removed and frozen [9]. Liver 
samples were stored at - 20°C until further pro- 
cessed. 
Livers were perfused at 37°C without recircula- 
tion with a Krebs-Ringer bicarbonate medium 
containing 10 mM glucose and 2.5% albumin. The 
medium was in equilibrium with 02/CO2 (19:l). 
After 30 min of perfusion, the livers were quick- 
frozen and further processed as indicated below. 
2.1. Measurement of phosphofructokinase and 
fructose 2,6_bisphosphate 
This work was undertaken to verify this hypo- 
thesis by measuring the content of fructose 2,6-bis- 
phosphate in livers of obese mice. 
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Phosphofructokinase activity was measured in 
extracts of livers as described previously [4]. The 
assay was performed in the presence of 0.1 mM 
AMP, 1.5 mM Mg-ATP, 1 mM NI-klCl, 5 mM 
MgC12,5 mM pi, 100 mM KCl, 50 mM HEPES at 
pH 7.1 and various concentrations of fructose 6- 
phosphate. Fructose 2,6-bisphosphate was mea- 
sured in heat-treated extracts by its ability to stim- 
ulate phosphofructokinase; details of the method 
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are given elsewhere [4,10]. An aliquot of each liver 
sample was also acid-treated to destroy fructose 
2,6-bisphosphate (pH 2, 20 min at 20°C). After 
neutralization, aliquots were tested to determine 
their ability to stimulate phosphofructokinase. 
This value, which represents stimulation by com- 
pounds other than fructose 2,6_bisphosphate, was 
subtracted from that obtained before the acid 
treatment. The difference represents the stimula- 
tion due to fructose 2,6-bisphosphate. To express 
the values obtained in nmol of fructose 2,6-bis- 
phosphate/g of tissue, the increase in phospho- 
fructokinase activity measured upon addition of 
heat-treated liver extracts, was compared with that 
obtained with pure fructose 2,6-bisphosphate (pre- 
pared as in [ 1 l] by Dr E. Van Schaftingen). 
2.2. Other methods 
Blood samples were deproteinized with equi- 
molar amounts of ZnS04 and Ba(OH)2 (121 and 
glucose was measured in the supernatant [13]. For 
the determination of glycogen, frozen livers were 
treated for 15 min at 100°C in the presence of 1 M 
KOH. After neutralization with 1.5 N acetic acid, 
glycogen was enzymically hydrolyzed into glucose 
[ 141 which was then measured [ 131. 
3. RESULTS 
The effect of substrate concentration on the ac- 
tivity of phosphofructokinase present in crude liver 
extracts was measured. Results (fig. 1) indicate that, 
in liver extracts of fed animals, phosphofructo- 
kinase from obese mice displayed a slightly greater 
affinity for fructose 6-phosphate than did the en- 
zyme from livers of lean controls. The difference 
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Fig. 1. Influence of fructose 6-phosphate concentration 
on the phosphofructokinase activity present in liver ex- 
tracts of lean and obese mice. The activity was measured 
as indicated in Materials and Methods. 
Table 1 
Glycaemia, glycogen and fructose 2,6_bisphosphate content of livers of 
lean and obese mice 
Glucose Glycogen Fructose 2,6_bisphosphate 
(mW (mg/g liver) (nmol/g of liver) 
Fed lean 8.1 f0.4 47 23 4.820.8 
Fed obese 8.5? 1.1 42 20.4 9.22 1.1 
Starved lean 5.920.5 5.2k0.9 0.7+0.1 
Starved obese 6.5 + 0.6 24 +2 4.6kO.3 
Values are means + SEM for 3 animals 
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was much larger when the saturation curve of 
phosphofructokinase from starved obese mice was 
compared with that of starved lean mice. Since 
these experiments were performed in crude ex- 
tracts of livers, the difference observed might be 
explained by the presence of different concentra- 
tions of fructose 2,6-bisphosphate in extracts of 
livers from obese and lean animals. The liver con- 
tent of fructose 2,6-bisphosphate was thus mea- 
sured in livers of fed and starved obese and lean 
mice. Glycaemia and liver glycogen content were 
also measured. Data are presented in table 1. 
There was no difference in glycaemia between 
control and obese mice. The glycogen content was 
the same in livers of fed obese and lean mice but, 
in livers of starved obese mice, it was 5-fold higher 
than in lean controls and represented about 50% of 
the value found in fed animals. The concentration 
of fructose 2,6-bisphosphate was almost twice as 
large in livers of fed obese mice as in livers of fed 
controls; in livers of starved obese mice the content 
was more than 6-fold higher than in starved lean 
controls. 
Since these values were obtained from intact 
anaesthetized animals, it was of interest to see 
whether the differences between obese and lean 
mice persisted in isolated liver preparations and 
was due solely to hepatic factors rather than extra- 
hepatic influences such as the presence of hor- 
mones. Fructose 2,6-bisphosphate was therefore 
measured in livers of starved animals which were 
perfused for 30 min in the presence of 10 mM 
glucose. The results (table 2) demonstrated that the 
difference persisted after perfusion of the liver, i.e., 
in the absence of hormones and that conditions re- 
quired for maintaining this difference were present 
in the isolated liver. 
Table 2 
Fructose 2,6-bisphosphate content of livers of lean and 
obese starved mice after 30 min of perfusion with 
10 mM glucose 
Fructose 2,6-bisphosphate 
(nmol/g of liver) 
Starved lean 0.8kO.l 
Starved obese 2.7k0.6 
Values are means + SEM for 3 preparations 
In livers of younger (12 week-old) fed mice, the 
difference in fructose 2,6-bisphosphate content be- 
tween control and obese mice was less important 
than with 25 week-old mice, the value for the 
obese animals being only l.Cfold larger than that 
of lean controls (results not shown). 
4. DISCUSSION 
Results reported here demonstrate the presence 
of fructose 2,6-bisphosphate in livers of mice. The 
concentrations measured are in the same order of 
magnitude as those previously reported for rat 
liver in vivo and for isolated rat hepatocytes [ 15- 
17]. In addition our results clearly show that livers 
of obese mice contain more fructose 2,6-bisphos- 
phate than their control littermates. The most 
striking difference was observed in livers of starved 
animals. In livers and hepatocytes from starved 
rats, the content of fructose 2,6-bisphosphate is 
several fold lower than in livers of fed animals 
[4,15]. This difference was also observed here in 
livers of lean mice. However, livers of starved 
obese mice still contained concentrations of fruc- 
tose 2,6-bisphosphate which were at least 6-fold 
higher than those of lean mice. This difference in 
fructose 2,6-bisphosphate content might explain 
the difference in the saturation curve of phospho- 
fructokinase for fructose 6-phosphate (fig. 1). Since 
fructose 2,6-bisphosphate is a potent positive effec- 
tor of phosphofructokinase which relieves inhibi- 
tion by ATP, the difference in fructose 2,6-bis- 
phosphate content observed may also explain the 
decreased sensitivity towards ATP inhibition 
which has been previously reported [3]. In a strain 
of genetically diabetic mice an opposite situation 
has been observed, namely an increased sensitivity 
df liver phosphofructokinase towards ATP inhibi- 
tion [ 181. It is not known whether the livers of these 
diabetic mice contain a decreased concentration of 
fructose 2,6-bisphosphate as is the case for alloxan 
diabetic rats [ 19,201. 
The presence of relatively increased concentra- 
tions of fructose 2,6-bisphosphate in livers of 
starved obese mice could contribute to keep an ac- 
tive glycolysis in the livers of these animals. There- 
fore the increased concentration of fructose 2,6- 
bisphosphate might also contribute to the in- 
creased lipogenesis by providing an increased sup- 
ply of lactate and pyruvate. This would indeed 
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give an explanation for the increased hepatic 
lipogenesis observed in obese mice during starva- 
tion [l]. 
What are the mechanisms involved in the main- 
tenance of an elevated fructose 2,6-bisphosphate in
livers of starved obese mice? Glucose and hor- 
mones such as glucagon are known to modulate 
fructose 2,6-bisphosphate content [4,5,17]. Since 
there was no difference in glycaemia between lean 
and obese animals, this factor is probably not re- 
sponsible for the difference. On the other hand, 
the immediate importance of hormonal factors can 
be ruled out since the difference persisted in per- 
fused livers, i.e., in the absence of hormones. The 
presence of glycogen and of an active glycogen- 
olysis is another factor which may lead to an ac- 
cumulation of fructose 2,6-bisphosphate by 
providing fructose 6-phosphate for the synthesis of 
fructose 2,6-bisphosphate [ 151. One may therefore 
speculate that, because of the higher concentration 
of glycogen in livers of starved obese mice, the 
concentration of hexose 6-phosphates is kept at a 
higher steady state level and so may cause the ac- 
cumulation of fructose 2,6-bisphosphate. Such a 
difference, although small, has already been ob- 
served [21]. The mechanisms involved in the main- 
tenance of a high glycogen content in livers of 
obese mice during starvation are however unclear. 
A decrease in the cyclic AMP content of livers of 
starved obese mice [22] might be of relevance. 
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